Pre‐emptive metoclopramide and ondansetron for nausea and vomiting associated with iloprost infusions
- 32 Downloads
Objective: To assess the effectiveness of ondansetron in relieving symptoms of nausea and vomiting which were refractory to metoclopramide and cyclizine, in a patient receiving iloprost infusions.Method: Case observation in a series of 7 infusions.Results: Ondansetron reduced WHO symptom scores of vomiting from Grade 2 to Grade 0. Symptoms of nausea were abolished on some occasions.Conclusion: Ondansetron was found to be effective at abolishing symptoms of vomiting and partially effective against symptoms of nausea. It may prove to be a useful treatment modality to allow the patient to tolerate further infusions of iloprost where nausea and vomiting has failed to respond to other agents.
- 1.Grant S, Goa K. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential on peripheral vascular disease, myocardial ischaemic and extracorporeal circulation procedures. Drugs 1992;43:889-924Google Scholar
- 2.Lawhorn S, Lawhorn C, Davison C. Ondansetron eliminates vomiting associated with prostacyclin in a patient awaiting lung transplantation. J Heart Lung Transplant 1997;16:472-3Google Scholar
- 3.Fisch A, Tobasch K, Veit K, Meyer J, Darius H. Prostacyclin receptor desensitisation is a reversible phenomenon in human platelets. Circulation 1997:96,756-60Google Scholar